Drug Type Bispecific antibody |
Synonyms- |
Target |
Mechanism IL6RB modulators(Interleukin-6 receptor subunit beta modulators), LEPR agonists(Leptin receptor agonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Obesity | Preclinical | US | 20 Jun 2019 |